ask="N/A"
ask_size="N/A"
average_daily_volume="2839500"
bid="N/A"
bid_size="N/A"
book_value="-0.151"
change="+0.013"
change_from_200_day_moving_average="0.270"
change_from_50_day_moving_average="0.320"
change_from_52_week_high="-0.167"
change_From_52_week_low="0.533"
change_in_percent="+1.667%"
close="0.793"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="0.464"
ebitda="-30.10M"
eps_estimate_current_year="-0.380"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-0.270"
ex_dividend_date="N/A"
float_shares="75832000"
high="0.820"
high_52_weeks="0.960"
last_trade_date="2/6/2017"
last_trade_price="0.793"
last_trade_size="731"
last_trade_time="4:00pm"
low="0.763"
low_52_weeks="0.260"
market_capitalization="79.16M"
moving_average_200_day="0.523"
moving_average_50_day="0.473"
name="Protalix BioTherapeutics
Inc. "
notes="N/A"
one_year_target_price="2.600"
open="0.780"
pe_ratio="1.709"
peg_ratio="-0.080"
percent_change_from_200_day_moving_average="+51.578%"
percent_change_from_50_day_moving_average="+67.609%"
percent_change_from_52_week_high="-17.396%"
percent_change_from_52_week_low="+205.000%"
previous_close="0.780"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="10.939"
revenue="7.12M"
shares_outstanding="99821000"
short_ratio="0.200"
stock_exchange="ASE"
symbol="PLX"
volume="3248224"
weeks_range_52="0.260 - 0.960"
